Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1V3A

Structure of human PRL-3, the phosphatase associated with cancer metastasis

1V3A の概要
エントリーDOI10.2210/pdb1v3a/pdb
分子名称protein tyrosine phosphatase type IVA (1 entity in total)
機能のキーワードhydrolase
由来する生物種Homo sapiens (human)
細胞内の位置Cell membrane: O75365
タンパク質・核酸の鎖数1
化学式量合計19566.90
構造登録者
Jeon, Y.H.,Cheong, C. (登録日: 2003-10-30, 公開日: 2004-10-30, 最終更新日: 2023-12-27)
主引用文献Kim, K.A.,Song, J.S.,Jee, J.,Sheen, M.R.,Lee, C.,Lee, T.G.,Ro, S.,Cho, J.M.,Lee, W.,Yamazaki, T.,Jeon, Y.H.,Cheong, C.
Structure of human PRL-3, the phosphatase associated with cancer metastasis
Febs Lett., 565:181-187, 2004
Cited by
PubMed Abstract: PRL-3, a novel class protein of prenylated tyrosine phosphatase, is important in cancer metastasis. Due to its high levels of expression in metastatic tumors, PRL-3 may constitute a useful marker for metastasis and might be a new therapeutic target. Here, we present the solution structure of the phosphatase domain of a human PRL-3 (residues 1-162) in phosphate-free state. The nuclear magnetic resonance (NMR) structure of PRL-3 is similar to that of other known phosphatases with minor differences in the secondary structure. But the conformation and flexibility of the loops comprising the active site differ significantly. When phosphate ions or sodium orthovanadate, which is a known inhibitor, are added to the apo PRL-3, the NMR signals from the residues in the active site appeared and could be assigned, indicating that the conformation of the residues has been stabilized.
PubMed: 15135076
DOI: 10.1016/j.febslet.2004.03.062
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
検証レポート(詳細版)ダウンロードをダウンロード

237735

件を2025-06-18に公開中

PDB statisticsPDBj update infoContact PDBjnumon